Terms: = Head and neck cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun
620 results:
1. The antitumor effects of herbal medicine Triphala on oral cancer by inactivating PI3K/Akt signaling pathway: based on the network pharmacology, molecular docking, in vitro and in vivo experimental validation.
Hu S; Li S; Xu Y; Huang X; Mai Z; Chen Y; Xiao H; Ning W; Gaus S; Savkovic V; Lethaus B; Zimmerer R; Acharya A; Ziebolz D; Schmalz G; Huang S; Zhao J; Hu X
Phytomedicine; 2024 Jun; 128():155488. PubMed ID: 38493718
[TBL] [Abstract] [Full Text] [Related]
2. Curcumin Analog L48H37 Induces Apoptosis in Human Oral cancer Cells by Activating Caspase Cascades and Downregulating the Inhibitor of Apoptosis Proteins through JNK/p38 Signaling.
Su CW; Kao SH; Chen YT; Hsieh YH; Yang WE; Tsai MY; Lin CW; Yang SF
Am J Chin Med; 2024; 52(2):565-581. PubMed ID: 38480502
[TBL] [Abstract] [Full Text] [Related]
3. Identification of key gene signatures and their characterization by expression correlation with drug sensitivity in smoking-associated oral squamous cell carcinoma.
Gollapalli P; Alagundagi D; Ghate SD; Shetty VV; Shetty P; Patil P
J Cancer Res Ther; 2023 Oct; 19(7):1743-1752. PubMed ID: 38376273
[TBL] [Abstract] [Full Text] [Related]
4. Transcriptomic analysis of Porphyromonas gingivalis-infected head and neck cancer cells: Identification of PLAU as a candidate prognostic biomarker.
Hamada M; Inaba H; Nishiyama K; Yoshida S; Yura Y; Matsumoto-Nakano M; Uzawa N
J Cell Mol Med; 2024 Feb; 28(4):. PubMed ID: 38363001
[TBL] [Abstract] [Full Text] [Related]
5. Stabilization of MOF (KAT8) by USP10 promotes esophageal squamous cell carcinoma proliferation and metastasis through epigenetic activation of ANXA2/Wnt signaling.
Li P; Yang L; Park SY; Liu F; Li AH; Zhu Y; Sui H; Gao F; Li L; Ye L; Zou Y; Tian Z; Zhao Y; Costa M; Sun H; Zhao X
Oncogene; 2024 Mar; 43(12):899-917. PubMed ID: 38317006
[TBL] [Abstract] [Full Text] [Related]
6. Protective Effect of Alpha-Linolenic Acid on Human Oral Squamous Cell Carcinoma Metastasis and Apoptotic Cell Death.
Su CC; Yu CC; Shih YW; Liu KL; Chen HW; Wu CC; Yang YC; Yeh EL; Li CC
Nutrients; 2023 Dec; 15(23):. PubMed ID: 38068849
[TBL] [Abstract] [Full Text] [Related]
7. CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1-positive regulator for tumor immune evasion.
Wang S; Iyer R; Han X; Wei J; Li N; Cheng Y; Zhou Y; Gao Q; Zhang L; Yan M; Sun Z; Fang D
J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 38038129
[TBL] [Abstract] [Full Text] [Related]
8. Disruption of CADM1-dependent cell-cell adhesion in human oral squamous cell carcinoma cells results in tumor progression, possibly through an increase of MMP-2 and MMP-9 expression.
Obara N; Kyakumoto S; Yamaguchi S; Yamada H; Ishisaki A; Kamo M
J Oral Biosci; 2024 Mar; 66(1):151-159. PubMed ID: 38030062
[TBL] [Abstract] [Full Text] [Related]
9. Network pharmacology to explore the molecular mechanisms of Prunella vulgaris for treating thyroid cancer.
Zhang Z; Zhou J; Guo R; Zhou Q; Wang L; Xiang X; Ge S; Cui Z
Medicine (Baltimore); 2023 Nov; 102(45):e34871. PubMed ID: 37960775
[TBL] [Abstract] [Full Text] [Related]
10. JNK2 Promotes Progression of Esophageal Squamous Cell Carcinoma
Wang L; Guo M; Gao L; Liu K; Bai J; Liu Z
Curr Pharm Des; 2023; 29(37):2977-2987. PubMed ID: 37957865
[TBL] [Abstract] [Full Text] [Related]
11. Systematic pharmacology-based strategy to explore the mechanism of Semen Strychni for treatment of papillary thyroid carcinoma.
Mao J; Tang L; Fang L; Tian C; Zhu Z; Li Y
Sci Rep; 2023 Oct; 13(1):18492. PubMed ID: 37898675
[TBL] [Abstract] [Full Text] [Related]
12. Network Pharmacological Analysis and Experimental Validation of the Effects of Silybin on Proliferation, Migration, and Immunotherapy of Papillary Thyroid cancer.
Xie W; Li H; Lin Q; Ke N
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):672-690. PubMed ID: 37855349
[TBL] [Abstract] [Full Text] [Related]
13. Qing Yan Li Ge Tang Induces Apoptosis in Human OEC-M1 Oral cancer Cells.
Yang CH; Wu YT; Tung KL; Huang BM; Lan YY
Altern Ther Health Med; 2023 Nov; 29(8):594-600. PubMed ID: 37678860
[TBL] [Abstract] [Full Text] [Related]
14. Combination
Gunda V; Ghosh C; Hu J; Zhang L; Zhang YQ; Shen M; Kebebew E
Thyroid; 2023 Oct; 33(10):1201-1214. PubMed ID: 37675898
[No Abstract] [Full Text] [Related]
15. Streptolysin S induces pronounced calcium-ion influx-dependent expression of immediate early genes encoding transcription factors.
Yamada T; Yamamori Y; Matsuda N; Nagamune H; Ohkura K; Tomoyasu T; Tabata A
Sci Rep; 2023 Aug; 13(1):13720. PubMed ID: 37608082
[TBL] [Abstract] [Full Text] [Related]
16. TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEap1/NRF2 signaling.
Xu T; Yang Y; Chen Z; Wang J; Wang X; Zheng Y; Wang C; Wang Y; Zhu Z; Ding X; Zhou J; Li G; Zhang H; Zhang W; Wu Y; Song X
J Exp Clin Cancer Res; 2023 Aug; 42(1):190. PubMed ID: 37525222
[TBL] [Abstract] [Full Text] [Related]
17. jun-induced super-enhancer RNA forms R-loop to promote nasopharyngeal carcinoma metastasis.
Jia Q; Tan Y; Li Y; Wu Y; Wang J; Tang F
Cell Death Dis; 2023 Jul; 14(7):459. PubMed ID: 37479693
[TBL] [Abstract] [Full Text] [Related]
18. Cisplatin-based combination therapy for cancer.
Minerva ; Bhat A; Verma S; Chander G; Jamwal RS; Sharma B; Bhat A; Katyal T; Kumar R; Shah R
J Cancer Res Ther; 2023; 19(3):530-536. PubMed ID: 37470570
[TBL] [Abstract] [Full Text] [Related]
19. Flubendazole inhibits PD-1 and suppresses melanoma growth in immunocompetent mice.
Li Y; Wu B; Hossain MJ; Quagliata L; O'Meara C; Wilkins MR; Corley S; Khachigian LM
J Transl Med; 2023 Jul; 21(1):467. PubMed ID: 37452307
[TBL] [Abstract] [Full Text] [Related]
20. Differences in Transcriptomic Profiles of Brain and Thyroid Tumors with NTRK Gene Rearrangement.
Kechin AA; Koryukov MA; Smertina MA; Borobova VS; Oscorbin IP; Ivanov AA; Bakharev SY; Boyarskikh UA; Kushlinskii NE; Filipenko ML
Bull Exp Biol Med; 2023 May; 175(1):78-85. PubMed ID: 37335445
[TBL] [Abstract] [Full Text] [Related]
[Next]
